The Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID) was established by the Department of Medicine to support both fundamental and translational research on human disease.
It houses up to 250 scientists working within 25 research groups. Our work focusses on understanding the pathogenesis and improving the management of immune-related disorders and transforming our understanding of how the infectious agents interact with humans.
CITIID transforms immunity and infection research in Cambridge by providing researchers with advanced facilities that are in close proximity and enable them to optimise their work on human immune, inflammatory and infectious diseases. By bringing together its clinical capabilities and key industry partners, CITIID is also well-placed to drive therapeutic breakthroughs, improve patient outcomes and advance population health both in the UK and abroad.
- CITIID successfully moves to the Jeffrey Cheah Biomedical Centre - We are delighted to announce that CITIID has completed a successful move to the Jeffrey Cheah Biomedical Centre (JCBC). The…
- Menna Clatworthy receives an EFIS-IL Lecture Award - Menna Clatworthy is a member of the Department of Medicine, located in the Cambridge Molecular Immunity Unit that is based…
- Wellcome Trust Fellowships awarded to members of our department - CITIID colleagues successfully receive Wellcome Trust Fellowships.